Propranolol as a pharmacological treatment of infantile haemangioma (IH) was first reported in 2008 and since then has become popular worldwide with positive clinical results and rare adverse events. IH became a new indication group for propranolol. Authors report a case of a 3-month-old child with a large infantile haemangioma of the face treated successfully with propranolol. In the submitted paper the recent knowledge about treatment of large IH with propranolol is reported, the probable mechanism of action and success of this treatment is documented in the case study.
|Translated title of the contribution||Current possibilities of infantile haemangioma treatment|
|Number of pages||4|
|Publication status||Published - 2013|
- Infantile hemangioma
- Pharmacological treatment
ASJC Scopus subject areas